The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Neuromuscular presentations in patients with COVID-19
Open accessAbstract
COVID-19 is caused by the coronavirus SARS-CoV-2 that has an affinity for neural tissue. There are reports of encephalitis, encephalopathy, cranial neuropathy, Guillain-Barrè syndrome, and myositis/rhabdomyolysis in patients with COVID-19. In this review, we focused on the neuromuscular manifestations of SARS-CoV-2 infection. We analyzed all published reports on SARS-CoV-2-related peripheral nerve, neuromuscular junction, muscle, and cranial nerve disorders. Olfactory and gustatory dysfunction is now accepted as an early manifestation of COVID-19 infection. Inflammation, edema, and axonal damage of olfactory bulb have been shown in autopsy of patients who died of COVID-19. Olfactory pathway is suggested as a portal of entry of SARS-CoV-2 in the brain. Similar to involvement of olfactory bulb, isolated oculomotor, trochlear and facial nerve has been described. Increasing reports Guillain-Barrè syndrome secondary to COVID-19 are being published. Unlike typical GBS, most of COVID-19-related GBS were elderly, had concomitant pneumonia or ARDS, more prevalent demyelinating neuropathy, and relatively poor outcome. Myalgia is described among the common symptoms of COVID-19 after fever, cough, and sore throat. Duration of myalgia may be related to the severity of COVID-19 disease. Few patients had muscle weakness and elevated creatine kinase along with elevated levels of acute-phase reactants. All these patients with myositis/rhabdomyolysis had severe respiratory complications related to COVID-19. A handful of patients with myasthenia gravis showed exacerbation of their disease after acquiring COVID-19 disease. Most of these patients recovered with either intravenous immunoglobulins or steroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis
Li, L., Huang, T., Wang, Y., Wang, Z., Liang, Y., Huang, T., Zhang, H., Sun, W., & Wang, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25757 · Cited by 1,487
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30109-5 · Cited by 993
Miller Fisher syndrome and polyneuritis cranialis in COVID-19
Gutiérrez-Ortiz, C., Méndez-Guerrero, A., Rodrigo-Rey, S., San Pedro-Murillo, E., Bermejo-Guerrero, L., Gordo-Mañas, R., de Aragón-Gómez, F., & Benito-León, J. (2020) · Neurology · doi:10.1212/wnl.0000000000009619 · Cited by 810
Lechien, J. R., Chiesa‐Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13089 · Cited by 800
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China
Zhang, J., Wang, X., Jia, X., Li, J., Hu, K., Chen, G., Wei, J., Gong, Z., Zhou, C., Yu, H., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.04.012 · Cited by 694
Anosmia and Ageusia: Common Findings in COVID‐19 Patients
Vaira, L. A., Salzano, G., Deiana, G., & De Riu, G. (2020) · The Laryngoscope · doi:10.1002/lary.28692 · Cited by 661
Neurologic alterations due to respiratory virus infections
Bohmwald, K., Gálvez, N. M. S., Ríos, M., & Kalergis, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00386 · Cited by 636
Guillain Barre syndrome associated with COVID-19 infection: A case report
Sedaghat, Z., & Karimi, N. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.04.062 · Cited by 575
Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43
Dubé, M., Le Coupanec, A., Wong, A. H. M., Rini, J. M., Desforges, M., & Talbot, P. J. (2018) · Journal of Virology · doi:10.1128/jvi.00404-18 · Cited by 452
Lai, X., Wang, M., Qin, C., Tan, L., Ran, L., Chen, D., Zhang, H., Shang, K., Xia, C., Wang, S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.9666 · Cited by 448
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 354
Rhabdomyolysis as Potential Late Complication Associated with COVID-19
Jin, M., & Tong, Q. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200445 · Cited by 338
Guillain-Barré syndrome related to COVID-19 infection
Alberti, P., Beretta, S., Piatti, M., Karantzoulis, A., Piatti, M. L., Santoro, P., Viganò, M., Giovannelli, G., Pirro, F., Montisano, D. A., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000741 · Cited by 335
COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
Dinkin, M., Gao, V., Kahan, J., Bobker, S., Simonetto, M., Wechsler, P., Harpe, J., Greer, C., Mints, G., Salama, G., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009700 · Cited by 327
Neurotropism of SARS-CoV 2: Mechanisms and manifestations
Conde Cardona, G., Quintana Pájaro, L. D., Quintero Marzola, I. D., Ramos Villegas, Y., & Moscote Salazar, L. R. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116824 · Cited by 261
Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., & Pisani, A. (2020) · European Journal of Neurology · doi:10.1111/ene.14277 · Cited by 260
Guillain-Barré Syndrome associated with SARS-CoV-2 infection
Virani, A., Rabold, E., Hanson, T., Haag, A., Elrufay, R., Cheema, T., Balaan, M., & Bhanot, N. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00771 · Cited by 252
[Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia].
Liu, M., He, P., Liu, H. G., Wang, X. J., Li, F. J., Chen, S., Lin, J., Chen, P., Liu, H., & Li, C. H. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0016 · Cited by 243
Biadsee, A., Biadsee, A., Kassem, F., Dagan, O., Masarwa, S., & Ormianer, Z. (2020) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599820934380 · Cited by 227
Guillain-Barré syndrome following COVID-19: new infection, old complication?
Padroni, M., Mastrangelo, V., Asioli, G. M., Pavolucci, L., Abu-Rumeileh, S., Piscaglia, M. G., Querzani, P., Callegarini, C., & Foschi, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09849-6 · Cited by 199
COVID‐19: a major cause of cachexia and sarcopenia?
Morley, J. E., Kalantar‐Zadeh, K., & Anker, S. D. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12589 · Cited by 197
Guillain‐Barr é syndrome during SARS‐CoV‐2 pandemic: A case report and review of recent literature
Scheidl, E., Canseco, D. D., Hadji‐Naumov, A., & Bereznai, B. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12382 · Cited by 185
Qiu, C., Cui, C., Hautefort, C., Haehner, A., Zhao, J., Yao, Q., Zeng, H., Nisenbaum, E. J., Liu, L., Zhao, Y., et al. (2020) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599820934376 · Cited by 170
Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease
Suwanwongse, K., & Shabarek, N. (2020) · Cureus · doi:10.7759/cureus.7561 · Cited by 162
Ottaviani, D., Boso, F., Tranquillini, E., Gapeni, I., Pedrotti, G., Cozzio, S., Guarrera, G. M., & Giometto, B. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04449-8 · Cited by 159
Olfactory and Gustatory Dysfunction in Coronavirus Disease 2019 (COVID-19)
Lüers, J.-C., Rokohl, A. C., Loreck, N., Matos, P. A. W., Augustin, M., Dewald, F., Klein, F., Lehmann, C., & Heindl, L. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa525 · Cited by 150
Mehraeen, E., Behnezhad, F., Salehi, M. A., Noori, T., Harandi, H., & SeyedAlinaghi, S. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06120-6 · Cited by 149
Lapostolle, F., Schneider, É., Vianu, I., Dollet, G., Roche, B., Berdah, J., Michel, J., Goix, L., Chanzy, É., Pétrovic, T., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02379-z · Cited by 147
Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis
Zhu, J., Zhong, Z., Ji, P., Li, H., Li, B., Pang, J., Zhang, J., & Zhao, C. (2020) · Family Medicine and Community Health · doi:10.1136/fmch-2020-000406 · Cited by 146
Bilateral transient olfactory bulb edema during COVID-19–related anosmia
Laurendon, T., Radulesco, T., Mugnier, J., Gérault, M., Chagnaud, C., Ahmadi, A.-A. E., & Varoquaux, A. D. (2020) · Neurology · doi:10.1212/wnl.0000000000009850 · Cited by 142
High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia
Alshukairi, A. N., Zheng, J. H., Zhao, J., Nehdi, A., Baharoon, S. A., Layqah, L. A., Bokhari, A. A., Johani, S. M. A., Samman, N., Boudjelal, M., et al. (2018) · mBio · doi:10.1128/mbio.01985-18 · Cited by 136
Covid-19 and Guillain-Barré syndrome: More than a coincidence!
Otmani, H. E., Moutawakil, B. E., Rafai, M. A., Benna, N. E., Kettani, C. E., Soussi, M., Mdaghri, N. E., Barrou, H., & Àfif, H. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.04.007 · Cited by 136
Lucchese, G., & Flöel, A. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01145-6 · Cited by 135
COVID-19–Associated Miller Fisher Syndrome: MRI Findings
Lantos, J. E., Strauß, S., & Lin, E. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6609 · Cited by 131
Caamaño, D. S. J., & Beato, R. A. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.05.016 · Cited by 128
Ferrandi, P. J., Alway, S. E., & Mohamed, J. S. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00321.2020 · Cited by 128
Incomplete and late recovery of sudden olfactory dysfunction in COVID-19
Kosugi, E. M., Lavinsky, J., Romano, F. R., Fornazieri, M. A., Matsumoto, G. R. L. L., Lessa, M. M., Piltcher, O. B., & Sant’Anna, G. D. (2020) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2020.05.001 · Cited by 125
Zhang, T., Sun, L. X., & Feng, R. E. (2020) · PubMed · doi:10.3760/cma.j.cn112147-20200311-00312 · Cited by 121
COVID ‐19 in patients with myasthenia gravis
Anand, P., Slama, M. C. C., Kaku, M. C., Ong, C. J., Cervantes-Arslanian, A. M., Zhou, L., David, W. S., & Guidon, A. C. (2020) · Muscle & Nerve · doi:10.1002/mus.26918 · Cited by 121
Chung, T. W., Sridhar, S., Zhang, J., Chan, K., Li, H., Wong, F. K.-C., Ng, M., Tsang, R. K., Lee, A. C.-Y., Fan, Z., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa199 · Cited by 113
Guillain-Barré syndrome as a complication of SARS-CoV-2 infection
Coen, M., Jeanson, G., Almeida, L., Hübers, A., Stierlin, F., Najjar, I., Ongaro, M., Moulin, K., Makrygianni, M., Leemann, B., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.074 · Cited by 109
Shah, S. J., Barish, P. N., Prasad, P. A., Kistler, A. L., Neff, N. F., Kamm, J., Li, L. M., Chiu, C. Y., Babik, J. M., Fang, M. C., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100518 · Cited by 109
Inflammatory olfactory neuropathy in two patients with COVID-19
Kirschenbaum, D. S., Imbach, L., Ulrich, S., Rushing, E. J., Keller, E., Reimann, R., Frauenknecht, K. B. M., Lichtblau, M., Witt, M., Hummel, T. R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31525-7 · Cited by 104
Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication
Webb, S., Wallace, V. C. J., Martín-López, D., & Yogarajah, M. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236182 · Cited by 102
COVID‐19 and herpes zoster co‐infection presenting with trigeminal neuropathy
Ferreira, A. C. A. D. F., Romão, T. T., Macedo, Y. S., Pupe, C., & Nascimento, O. J. M. (2020) · European Journal of Neurology · doi:10.1111/ene.14361 · Cited by 100
Taste and Smell Impairment in COVID‐19: An AAO‐HNS Anosmia Reporting Tool‐Based Comparative Study
Sayın, İ., Yaşar, K. K., & Yazıcı, Z. M. (2020) · Otolaryngology · doi:10.1177/0194599820931820 · Cited by 99
Miller‐Fisher syndrome after SARS‐CoV‐2 infection
Bueno, J. A. R., Trujillo, L. G., Urbaneja, P., Ciano-Petersen, N. L., Postigo-Pozo, M. J., Martínez‐Tomás, C., & Serrano-Castro, P. J. (2020) · European Journal of Neurology · doi:10.1111/ene.14383 · Cited by 98
A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2
Wei, X., Wang, X.-R., Zhang, J.-C., Yang, W.-B., Ma, W.-L., Yang, B., Jiang, N., Gao, Z.-C., Shi, H.-Z., & Zhou, Q. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.04.013 · Cited by 96
Pediatric COVID-19-associated rhabdomyolysis: a case report
Gefen, A. M., Palumbo, N., Nathan, S. K., Singer, P. S., Castellanos-Reyes, L. J., & Sethna, C. B. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04617-0 · Cited by 87
Post SARS-CoV-2 Guillain-Barré syndrome
Arnaud, S., Budowski, C., Tin, S. N. W., & Degos, B. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.05.003 · Cited by 84
Chan, K. H., Farouji, I., Hanoud, A. A., & Slim, J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.05.015 · Cited by 79
Olfactory and gustatory abnormalities in COVID-19 cases
Altın, F., Cingi, C., Uzun, T., & Bal, C. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06155-9 · Cited by 79
Korkmaz, M. F., Türe, E., Dorum, B. A., & Kılıç, Z. B. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e236 · Cited by 78
Peyronnet, V., Sibiude, J., Deruelle, P., Huissoud, C., Lescure, F.-X., Lucet, J. C., Mandelbrot, L., Nisand, I., Vayssière, C., Yazpandanah, Y., et al. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.03.014 · Cited by 77
Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report
Aoyagi, Y., Ohashi, M., Funahashi, R., Otaka, Y., & Saitoh, E. (2020) · Dysphagia · doi:10.1007/s00455-020-10140-z · Cited by 73
COVID 19 infection presenting as motor peripheral neuropathy
Abdelnour, L. H., Abdalla, M. E., & Babiker, S. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.04.024 · Cited by 72
Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection
Chan, J. L., Ebadi, H., & Sarna, J. R. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.106 · Cited by 72
SARS‐CoV‐2 and Guillain–Barré syndrome: AIDP variant with a favourable outcome
Lascano, A. M., Epiney, J., Coen, M., Serratrice, J., Bernard‐Valnet, R., Lalive, P. H., Küntzer, T., & Hübers, A. (2020) · European Journal of Neurology · doi:10.1111/ene.14368 · Cited by 72
Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection
Saldaña, A. S., Gil, Á. L., Liesa, J. L. C., Caballo, M. R. B., Haddad-Garay, M., Rivero-Celada, D., & Ponz, M. S. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0213 · Cited by 69
Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019
Lee, D. J., Lockwood, J., Das, P., Wang, R., Grinspun, E., & Lee, J. M. (2020) · Canadian Journal of Emergency Medicine · doi:10.1017/cem.2020.420 · Cited by 66
Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection
Chaumont, H., San‐Galli, A., Martino, F., Couratier, C., Joguet, G., Carlès, M., Roze, E. F., & Lannuzel, A. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09986-y · Cited by 66
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19
Valente-Acosta, B., Moreno‐Sánchez, F., Fueyo, O., & Palomar-Lever, A. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236719 · Cited by 58
COVID-19–Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome
Hutchins, K. L., Jansen, J. H., Comer, A. D., Scheer, R. V., Zahn, G. S., Capps, A. E., Weaver, L., & Koontz, N. A. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6654 · Cited by 57
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
Ramaswamy, S. B., & Govindarajan, R. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200520 · Cited by 52
Guillain–Barré syndrome after SARS‐CoV‐2 infection
Kilinc, D., van de Pasch, S., Doets, A. Y., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14398 · Cited by 51
Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2
Helbok, R., Beer, R., Löscher, W. N., Boesch, S., Reindl, M., Hornung, R., Schiefecker, A. J., Deisenhammer, F., & Pfausler, B. (2020) · European Journal of Neurology · doi:10.1111/ene.14388 · Cited by 50
Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit
Madia, F., Merico, B., Primiano, G., Cutuli, S. L., PASCALE, G. D., & Servidei, S. (2020) · Neurology · doi:10.1212/wnl.0000000000010280 · Cited by 50
Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report
Farzi, M. A., Ayromlou, H., Jahanbakhsh, N., Bavil, P. H., Janzadeh, A., & Shayan, F. K. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577294 · Cited by 45
Síndrome de Guillain-Barré fatal tras infección por el virus SARS-CoV-2
Marta-Enguita, J., Rubio-Baines, I., & Gastón-Zubimendi, I. (2020) · Neurología · doi:10.1016/j.nrl.2020.04.004 · Cited by 45
Altwairqi, R. G., Aljuaid, S. M., & Alqahtani, A. S. (2019) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-019-05672-6 · Cited by 42
Fatal Guillain-Barre syndrome after infection with SARS-CoV-2
Marta-Enguita, J., Rubio-Baines, I., & Gastón-Zubimendi, I. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.04.004 · Cited by 42
Kang, Y. J., Cho, J. H., Lee, M. H., Kim, Y. J., & Park, C. (2020) · Auris Nasus Larynx · doi:10.1016/j.anl.2020.05.020 · Cited by 41
Iglesias, P. G., Porta-Etessam, J., Montalvo, T., Carbó, A. V., Gajate-García, V., Matías‐Guiu, J. A., Parejo‐Carbonell, B., González-García, N., Ezpeleta, D., Laínez, J. M., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00243 · Cited by 36
Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis
Uysal, B. B., İkitimur, H., Yavuzer, S., İslamoğlu, M. S., & Cengız, M. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0583 · Cited by 32
Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019
Chen, Y., Zhao, M., Wu, Y., & Zang, S. (2020) · Journal of Global Health · doi:10.7189/jogh.10.011004 · Cited by 26
Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19)
Ghiasvand, F., Ghadimi, M., Ghadimi, F., Safarpour, S., Hosseinzadeh, R., & SeyedAlinaghi, S. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00815 · Cited by 25
Is delayed cardioversion the better approach in recent-onset atrial fibrillation? Yes
Botto, G. L., & Tortora, G. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02225-x · Cited by 17
Cited by
New Onset of Autoimmune Diseases Following COVID-19 Diagnosis
Gracia-Ramos, A. E., Martin-Nares, E., & Hernández-Molina, G. (2021) · Cells · doi:10.3390/cells10123592 · Cited by 296
Neuromuscular Diseases Care in the Era of COVID-19
Bertran Recasens, B., & Rubio, M. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.588929 · Cited by 43
“This could explain why some patients have persistent anosmia or other cranial neuropathies (3, 4).”
Background
Metadata
- Authors
- Paliwal, V. K., Garg, R. K., Gupta, A., & Tejan, N.
- Venue
- Neurological Sciences
- Published
- 2020-09-15
- Volume
- 41
- Issue
- 11
- Pages
- 3039-3056
- ISSN
- 1590-1874 (ISSN-L)
- 1590-3478
- OpenAlex
- W3086751973
- Cited by
- 266
- References
- 87
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.